FX Newborn Screening Study Logo graphic dot  
title
[en español]
graphic dot

What is the purpose of this study?

The purpose of this study is to screen for Fragile X. Fragile X is NOT included in your baby's routine newborn screening. Being in this study means that your baby will have an extra test that is not part of the state newborn screening program. We hope to learn more about the benefits and problems in newborn screening for Fragile X from the families who participate in this study. We also want to learn more about how families respond and adapt when their newborn is identified with a change in the gene.

Please note, the Fragile X screening in this study is experimental, and it is not a diagnostic test. We cannot guarantee that the screening test will find all cases of Fragile X. The study is not intended to find other genetic causes of disability, developmental delay, or medical problems.

View a copy of the consent form, which includes details about the benefits and risks of participation in this study.  consent


UNC FPG RTI
  For technical assistance, please contact the Webmaster.

 

Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant No. 5P30HD3110-40-S1, and by the Ethical, Legal, and Social Implications Research Program of the National Human Genome Research Institute, Grant No. P50HG004488.